Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.4 USD | -0.23% | +0.13% | +53.05% |
Chart calendar Calliditas Therapeutics AB
Upcoming events on Calliditas Therapeutics AB
Past events on Calliditas Therapeutics AB
30/05/2024 14:00 | R&D Day |
26/05/2024 07:54 | European Renal Association Congress - Poster No 2533 |
25/05/2024 14:15 | European Renal Association Congress - Oral Poster No 501129 |
25/05/2024 09:15 | European Renal Association Congress |
23/05/2024 13:30 | Q1 2024 Earnings Call |
23/05/2024 06:00 | Q1 2024 Earnings Release |
28/04/2024 | LSX World Congress |
24/04/2024 | World Orphan Drug Congress |
15/04/2024 | Van Lanschot Kempen Life Sciences Conference |
15/04/2024 17:45 | ISN World Congress - Evolving Landscape of eGFR |
14/04/2024 21:45 | ISN World Congress - Poster No: SUN-037 |
14/04/2024 21:45 | ISN World Congress - Poster No: SUN-036 |
14/04/2024 21:45 | ISN World Congress - Poster No: SUN-050 |
14/04/2024 21:45 | ISN World Congress - Poster No: SUN-034 |
12/03/2024 | Jefferies Biotech on the Bay Summit |
11/03/2024 | Leerink Partners Global Biopharma Conference |
06/03/2024 09:20 | Carnegie Healthcare Conference |
21/02/2024 13:30 | Q4 2023 Earnings Call |
21/02/2024 06:43 | Q4 2023 Earnings Release |
08/02/2024 16:00 | Guggenheim Healthcare Talks Biotechnology Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 185 184 0.39% | 0,87 0,29 205.61% | 229 202 13.64% | 803 634 26.67% | 1 207 1 130 6.78% | 1 868 |
EBITDA Million SEK | Released Forecast Spread | -28,0 -29,5 5.23% | -380 -332 -14.26% | -524 -519 -1.11% | -422 -497 15.07% | -373 -472 20.91% | 72,5 |
EBIT Million SEK | Released Forecast Spread | -28,0 -29,5 5.17% | -380 -353 -7.45% | -524 -533 1.66% | -422 -520 18.85% | -373 -495 24.64% | 24,6 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -32,5 -15,7 -107.54% | -436 -373 -17% | -513 -536 4.21% | -409 -493 16.97% | -457 -531 13.94% | -63,0 |
Net income Million SEK | Released Forecast Spread | -32,6 -15,7 -108.03% | -433 -373 -16.26% | -500 -540 7.43% | -412 -469 12.15% | -466 -516 9.67% | -63,9 |
EPS SEK | Released Forecast Spread | -0,88 -0,41 -114.63% | -9,66 -7,14 -35.29% | -9,84 -9,24 -6.49% | -7,78 -7,90 1.54% | -8,69 -9,01 3.58% | 5,57 |
Announcement Date | 14/02/20 | 18/02/21 | 24/02/22 | 23/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 49,7 49,2 1.14% | 64,0 78,3 -18.23% | 260 137 89.79% | 429 204 110.27% | 191 232 -17.52% | 269 286 -5.77% | 295 331 -10.89% | 452 386 16.84% | 295 383 -22.8% | 459 | 516 | 604 | 678 | 751 |
EBITDA Million SEK | Released Forecast Spread | -208 -233 10.55% | -210 -251 16.39% | -36,2 -181 80.01% | 32,5 -87,8 137% | -180 -137 -31.14% | -75,2 -111 32.17% | -160 -60,0 -165.84% | 41,8 -77,2 154.13% | -204 -85,2 -139.13% | -14,9 | 60,1 | 144 | ||
EBIT Million SEK | Released Forecast Spread | -208 -252 17.39% | -210 -241 12.92% | -36,2 -219 83.47% | 32,5 -118 127.57% | -180 -135 -33.64% | -75,2 -105 28.63% | -160 -68,0 -134.58% | 41,8 -77,2 154.1% | -204 -27,2 -650.37% | -9,63 | 47,6 | 126 | ||
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -211 -270 21.71% | -192 -243 21.05% | -16,0 -227 92.97% | 10,1 -126 108.01% | -208 -148 -40.79% | -70,7 -131 45.97% | -164 -79,7 -105.8% | -14,3 -100 85.79% | -247 -45,6 -442.11% | -27,0 | 22,7 | 100 | ||
Net income Million SEK | Released Forecast Spread | -207 -257 19.36% | -192 -243 20.74% | -9,11 -226 95.97% | -3,68 -124 97.04% | -188 -138 -35.8% | -91,9 -119 22.94% | -168 -77,7 -116.6% | -18,4 -100 81.7% | -246 -47,2 -421.97% | -28,6 | 21,0 | 98,2 | ||
EPS SEK | Released Forecast Spread | -3,62 -4,94 26.67% | -0,17 -2,99 94.32% | -0,07 -1,71 95.9% | -3,49 -1,70 -105.21% | -1,71 -3,07 44.25% | -3,14 -0,76 -313.87% | -0,34 -1,70 79.95% | -4,59 -2,10 -118.57% | 0,50 | 1,30 | 7,40 | |||
Announcement Date | 18/05/22 | 18/08/22 | 14/11/22 | 23/02/23 | 16/05/23 | 17/08/23 | 07/11/23 | 21/02/24 | 23/05/24 | - | - | - | - | - |
Past sector events for Calliditas Therapeutics AB
23/05/2024 06:00 | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
15/05/2024 06:00 | MERCK KGAA: Q1 2024 Earnings Release |
13/05/2024 | OSCOTEC INC.: Q1 2024 Earnings Release |
13/05/2024 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
08/05/2024 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
08/05/2024 21:05 | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
06/05/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
06/05/2024 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
29/04/2024 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
29/04/2024 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CALTX Stock
- CALT Stock
- Calendar Calliditas Therapeutics AB